Andrew Louis
Andrew Louis Abendschein, Longmont, CO US
Patent application number | Description | Published |
---|---|---|
20130034086 | SYSTEM AND METHODS FOR SYNCHRONIZING EDGE DEVICES ON CHANNELS WITHOUT CARRIER SENSE - A system and method are disclosed for synchronizing edge devices on a network, wherein the network has limited bandwidth and does not support a practical carrier sense mechanism. The edge devices transmit, using a slotted protocol, to a server located at a central data aggregation point. The server also controls a Central Transmitter, which sends messages to the edge devices to assign transmission slots and provide timing information to the edge devices to ensure that transmissions sent by devices sharing the same communication channel do not collide. | 02-07-2013 |
20140233662 | A SYSTEM AND METHOD FOR INFERRING SCHEMATIC AND TOPOLOGICAL PROPERTIES OF AN ELECTRICAL DISTRIBUTION GRID - A system and method for inferring schematic and topological properties of an electrical distribution grid is provided. The system may include Remote Hubs, Subordinate Remotes, a Substation Receiver, and an associated Computing Platform and Concentrator. At least one intelligent edge transmitter, called a Remote Hub Edge Transmitter, may transmit messages on the electrical distribution grid by injecting a modulated current into a power main that supplies an electric meter. The Subordinate Remotes, Remote Hubs, the Substation Receiver, and the associated Computing Platform and Concentrator may contain processing units which execute stored instructions allowing each node in the network to implement methods for organizing the on-grid network and transmitting and receiving messages on the network. The Substation Receiver, Computing Platform and Concentrator may detect and infer schematic grid location attributes of the network and publish the detected and inferred attributes to other application systems including geospatial information systems maintaining the logical and physical network model. | 08-21-2014 |
Andrew Louis Krivonak, Lawrence Park, PA US
Patent application number | Description | Published |
---|---|---|
20150313002 | METHOD AND APPARATUS FOR MECHANICAL LOAD REDUCTION ON THE ELECTRICAL TERMINALS OF A CAPACITOR - In an embodiment, an apparatus for reducing the mechanical load on the electrical terminals of a capacitor includes a plate having a planar body and one or more deflectable tabs connected to the planar body, one or more capacitors respectively mounted to the plate via the one or more deflectable tabs, and a busbar electrically connected to the one or more capacitors such that the one or more capacitors are arranged intermediate the plate and the busbar. The deflectable tabs are configured to support the capacitors, and to move towards and away from the planar body for accommodating size variances in the capacitors relative to a fixed spacing between the busbar and an enclosure. | 10-29-2015 |
Andrew Louis Norell, St. Albert CA
Patent application number | Description | Published |
---|---|---|
20090196747 | COMPACT VARIABLE PITCH FAN - A compact variable pitch fan has a hydraulic pitch change mechanism. A pitch change piston is constrained to follow reciprocating motion under hydraulic control within a peripheral hub from which fan blades extend outward. An additional feature is the use of separated guiding and seal surfaces. A still further feature is the use of a pitch sensor, particularly on the hydraulic line leading to the variable pitch fan. | 08-06-2009 |
Andrew Louis Strahs, Maynard, MA US
Patent application number | Description | Published |
---|---|---|
20090061423 | PHARMACOGENOMIC MARKERS FOR PROGNOSIS OF SOLID TUMORS - The present invention provides methods, systems and equipment for prognosis or evaluation of treatment of solid tumors. Gene markers that are prognostic of solid tumors can be identified according to the present invention. Each gene marker has altered expression patterns in PBMCs of solid tumor patients following initiation of an anti-cancer treatment, and the magnitudes of these alterations are correlated with clinical outcomes of these patients. In one embodiment, a Cox proportional hazards model is used to determine the correlations between clinical outcomes of RCC patients and gene expression changes in PBMCs of these patients during the course of a CCI-779 treatment. Non-limiting examples of genes identified by the Cox model are depicted in Tables 4A3 4B, 5 A and 5B. These genes can be used as surrogate markers for prognosis of RCC. They can also be used as pharmacogenomic indicators for the efficacy of CCI-779 or other anti-cancer drugs. | 03-05-2009 |
20120010240 | CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR - A cut-point in the quantitative measurement of PTEN protein expression that accurately identifies tumors with two inactivated alleles of the PTEN gene. Patients with a normalized PTEN score of PTEN null will be treated with a pan-ErbB tyrosine kinase inhibitor. A normalized PTEN protein expression score is obtained by comparing the tumor PTEN OD expression value with the non-malignant PTEN OD expression value. | 01-12-2012 |
20130189274 | PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS - Methods for treating breast cancer, specifically cancers resistant to treatment with one or more known breast cancer treatment drugs, and related patient selection strategies for predicting patient response to drug therapy, such strategies including detecting the presence or absence in a patient of one or more of PIK3CA gene amplification, a mutation in PIK3CA, and a decrease in PTEN protein expression, and treating a patient positive for the presence of one or more of same by administering to the subject a pan-ErbB tyrosine kinase inhibitor. | 07-25-2013 |